Titlebook: Biopharmaceutical Drug Design and Development; Susanna Wu-Pong (Director),Yon Rojanasakul (Profes Book 2008Latest edition Humana Press 200

Instantaneous

T. Kawaguchi,K. Hishida,M. Maedas may account for as much as 30% of interindividual differences in drug disposition and response. An increasing number of drug target polymorphisms have also been linked to differences in drug response. This chapter reviews some examples of the use of pharmacogenetics in clinical practice. Despite t

liaison

explicit

可耕種

龍蝦

R. J. Adrian,D. F. G. Durao,J. H. Whitelaw no FOPP have yet been approved in the US or European pharmaceutical market. This is because of a lack of registration process for the demonstration of pharmaceutical and therapeutic/clinical equivalence. The production of FOPP is a significant opportunity for patients, managed health care providers

高原

Defraud

Microarray Technology Using Proteins, Cells, and Tissues,analysis. This chapter reviews the current status of protein microarray assays and highlights efforts using cells and tissues on microarrays. These ‘other’ microarrays have the potential to yield highly parallel miniaturized assays that will accelerate drug discovery efforts and facilitate understanding of biological complexity.

有節(jié)制

無(wú)脊椎

http://image.papertrans.cn/b/image/188315.jpg

要素

https://doi.org/10.1007/978-3-540-45867-8analysis. This chapter reviews the current status of protein microarray assays and highlights efforts using cells and tissues on microarrays. These ‘other’ microarrays have the potential to yield highly parallel miniaturized assays that will accelerate drug discovery efforts and facilitate understanding of biological complexity.